Format

Send to

Choose Destination
Mov Disord. 2019 Mar;34(3):442. doi: 10.1002/mds.27611.

Adrenoceptor agonists and antagonists and risk of Parkinson's disease.

Author information

1
Department of Neurology, Cedars Sinai Medical Center, Los Angeles, California, USA.
2
Neurodegeneration Imaging Group, King's College London, London, United Kingdom.
PMID:
30875150
DOI:
10.1002/mds.27611

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center